Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' HECQUET B' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 45 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. MAIGNE J; DESCHATRETTE J; SARRAZIN S; HECQUET B; GUERROUI S; WOLFROM C
      THE TIME-PATTERN OF RISES AND FALLS IN PROLIFERATION FADES WITH SENESCENCE OF MORTAL LINES AND IS PERPETUATED IN IMMORTAL RAT HEPATOMA FAO CELL-LINE

      In vitro cellular & developmental biology. Animal
    2. DALLONGEVILLE J; HECQUET B; LEBEL P; EDME JL; LEFUR C; FRUCHART JC; AUWERX J; ROMON M
      SHORT-TERM RESPONSE OF CIRCULATING LEPTIN TO FEEDING AND FASTING IN MAN - INFLUENCE OF CIRCADIAN CYCLE

      International journal of obesity
    3. MORMONT MC; HECQUET B; BOGDAN A; BENAVIDES M; TOUITOU Y; LEVI F
      NONINVASIVE ESTIMATION OF THE CIRCADIAN-RHYTHM IN SERUM CORTISOL IN PATIENTS WITH OVARIAN OR COLORECTAL-CANCER

      International journal of cancer
    4. ADENIS A; VENNIN P; HECQUET B
      WHAT DO GASTROENTEROLOGISTS, SURGEONS AND ONCOLOGISTS TELL PATIENTS WITH COLON-CANCER - RESULTS OF A SURVEY FROM THE NORTHERN FRANCE AREA

      Bulletin du cancer
    5. WATTEL E; SOLARY E; HECQUET B; CAILLOT D; IFRAH N; BRION A; MAHE B; MILPIED N; JANVIER M; GUERCI A; ROCHANT H; CORDONNIER C; DREYFUS F; BUZYN A; HOANGNGOC L; STOPPA AM; GRATECOS N; SADOUN A; STAMATOULAS A; TILLY H; BRICE P; MALOISEL F; LIOURE B; DESABLENS B; PIGNON B; ABGRALL JP; LEPORRIER M; DUPRIEZ B; GUYOTAT D; LEPELLEY P; FENAUX P
      QUININE IMPROVES THE RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES EXPRESSING P-GLYCOPROTEIN - RESULTS OF A RANDOMIZED STUDY

      British Journal of Haematology
    6. WATTEL E; SOLARY E; HECQUET B; CAILLOT D; IFRAH N; BRION A; MILPIED N; JANVIER M; GUERCI A; ROCHANT H; CORDONNIER C; DREYFUS F; VEIL A; HOANGNGOC L; STOPPA AM; GRATECOS N; SADOUN A; TILLY H; BRICE B; GUYOTAT D; LEPELLEY P; FENAUX P
      QUININE IMPROVES RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTICSYNDROMES (MDS) EXPRESSING P-GLYCOPROTEIN (PGP) - UPDATED RESULTS OF A RANDOMIZED STUDY

      British Journal of Haematology
    7. VILAIN MO; DELOBELLEDEROIDE A; BLOGET F; CABARET V; PEYRAT JP; FOURNIER C; HECQUET B; FOURNIER J; VENNIN P; BONNETERRE J
      IMMUNOHISTOCHEMICAL DETECTION OF ESTROGEN AND PROGESTERONE RECEPTORS IN FORMALIN-FIXED, PARAFFIN-EMBEDDED TISSUES AFTER MICROWAVE TREATMENT- COMPARISON WITH BIOCHEMICAL ASSAY IN A SERIES OF 123 BREAST CARCINOMAS WITH DETERMINATION OF THE POSITIVITY CUTOFF

      Annales de pathologie
    8. LI XM; METZGER G; FILIPSKI E; BOUGHATTAS N; LEMAIGRE G; HECQUET B; FILIPSKI J; LEVI F
      PHARMACOLOGICAL MODULATION OF REDUCED GLUTATHIONE CIRCADIAN-RHYTHMS WITH BUTHIONINE SULFOXIMINE - RELATIONSHIP WITH CISPLATIN TOXICITY IN MICE

      Toxicology and applied pharmacology
    9. HECQUET B
      THE AREA-UNDER-THE-CURVE

      Bulletin du cancer
    10. PUNT CJA; VOEST EE; TUENI E; VANOOSTEROM AT; BACKX A; DEMULDER PHM; HECQUET B; LUCAS C; GERARD B; BLEIBERG H
      PHASE IB STUDY OF DOXORUBICIN IN COMBINATION WITH THE MULTIDRUG-RESISTANCE REVERSING AGENT S9788 IN ADVANCED COLORECTAL AND RENAL-CELL CANCER

      British Journal of Cancer
    11. EDME JL; LEFUR C; HECQUET B; DALLONGEVILLE J; ROMON M
      INFLUENCE OF THE BASE-LINE CHOSEN ON THE CALCULATION OF POSTPRANDIAL THERMOGENESIS IN CHRONOBIOLOGY

      Archives of physiology and biochemistry
    12. LUQUET C; CHAU N; NADIF M; GUILLEMIN F; GAVILLOT C; PETRY D; MOREAU T; BOURGKARD E; HECQUET B; ANDRE JM; MUR JM
      UNIDIMENSIONALITY OF A FUNCTIONAL MEASURE FOR PATIENTS WITH INJURED UPPER-LIMB

      Revue d'epidemiologie et de sante publique
    13. ADENIS A; VANLEMMENS L; FOURNIER C; HECQUET B; BONNETERRE J
      DOES INDUCTION CHEMOTHERAPY WITH A MITOXANTRONE VINORELBINE REGIMEN ALLOW A BREAST-CONSERVATIVE TREATMENT IN PATIENTS WITH OPERABLE LOCOREGIONAL BREAST-CANCER - A FRENCH NORTHERN ONCOLOGY GROUP TRIAL IN 105 PATIENTS/

      Breast cancer research and treatment
    14. CAPPELAERE P; FOURNIER C; ROLLAND F; MEEUS L; DOMENGE C; KRAKOWSKI I; DEGISLAIN C; CHAUVERGNE J; DUFOURESQUERRE F; PION JM; HECQUET B
      PREDICTIVE VALUE OF HEMATOLOGICAL COUNTS AT THE 4TH DAY AFTER CARBOPLATIN-FLUOROURACIL REGIMEN FOR NEUTRO AND OR THROMBOPENIA/

      Bulletin du cancer
    15. WATTEL E; GUERCI A; HECQUET B; ECONOMOPOULOS T; COPPLESTONE A; MAHE B; COUTEAUX ME; RESEGOTTI L; VOGLOVA V; FOUSSARD C; PEGOURIE B; MICHAUX JJ; DECONINCK E; STOPPA AM; MUFTI G; OSCIER D; FENAUX P
      A RANDOMIZED TRIAL OF HYDROXYUREA VERSUS VP16 IN ADULT CHRONIC MYELOMONOCYTIC LEUKEMIA

      Blood
    16. LEFEBVRE JL; BUISSET E; COCHEDEQUEANT B; VAN JT; PREVOST B; HECQUET B; DEMAILLE A
      EPILARYNX - PHARYNX OR LARYNX

      Head & neck
    17. ADENIS A; PEYRAT JP; HECQUET B; DELOBELLE A; DEPADT G; QUANDALLE P; BONNETERRE J; DEMAILLE A
      TYPE-I INSULIN-LIKE GROWTH-FACTOR RECEPTORS IN HUMAN COLORECTAL-CANCER

      European journal of cancer
    18. PREUDHOMME C; DERVITE I; WATTEL E; VANRUMBEKE M; FLACTIF M; LAI JL; HECQUET B; COPPIN MC; NELKEN B; GOSSELIN B; FENAUX P
      CLINICAL-SIGNIFICANCE OF P53 MUTATIONS IN NEWLY-DIAGNOSED BURKITTS-LYMPHOMA AND ACUTE LYMPHOBLASTIC-LEUKEMIA - A REPORT OF 48 CASES

      Journal of clinical oncology
    19. ADENIS A; HUET G; ZERIMECH F; HECQUET B; BALDUYCK M; PEYRAT JP
      CATHEPSIN-B, CATHEPSIN-L, AND CATHEPSIN-D ACTIVITIES IN COLORECTAL CARCINOMAS - RELATIONSHIP WITH CLINICOPATHOLOGICAL PARAMETERS

      Cancer letters
    20. NGUYENPAMART M; BONNETERRE J; HECQUET B
      URINARY-EXCRETION OF DEOXYPYRIDINOLINE IN PATIENTS WITH BREAST-CANCER

      Anticancer research
    21. VENNIN P; HECQUET B; MARCUZZI I; DEMAILLE MC
      INFORMATION AND PARTICIPATION PREFERENCES AMONG PATIENTS WITH BREAST-CANCER AND THEIR DOCTORS

      Bulletin du cancer
    22. CAPPELAERE P; HECQUET B; ROLLAND F; MEEUS L; DOMENGE C; KRAKOWSKI I; DEGISLAIN C; CHAUVERGNE J; DUFOURESQUERRE F; CARDE P
      RANDOMIZED TRIAL OF MYELOPREVENTION BY GORALATINE VS PLACEBO FOR PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA, TREATED BY CARBOPLATIN-FLUOROUROCILE

      Bulletin du cancer
    23. BONNETERRE J; HECQUET B
      GRANISETRON (IV) COMPARED WITH ONDANSETRON (IV PLUS ORAL) IN THE PREVENTION OF NAUSEA AND VOMITING INDUCED BY MODERATELY-EMETOGENIC CHEMOTHERAPY - A CROSS-OVER STUDY

      Bulletin du cancer
    24. HEBBAR M; HECQUET B; VANLEMMENS L; LECOMTE S; PION JM; ADENIS A; BONNETERRE J
      INSUFFICIENT EFFICACY OF THE USE OF ONE 8 -MG TABLET ONDANSETRON IN THE PREVENTION OF FEC CHEMOTHERAPY-INDUCED EMESIS

      Bulletin du cancer
    25. HECQUET B
      COMPUTERS AND PHARMACOKINETICS, BAYESIAN STATISTICS AND POPULATION PHARMACOKINETICS

      Bulletin du cancer
    26. RIVIERE A; BECKENDORF V; BONNETERRE J; BUI NB; CATIMEL G; CUPISSOL D; FARGEOT P; HECQUET B; KRAKOWSKI I; MADELAINECHAMBRIN I; MIHURA J; ROCHE H; RUFFIE P; SCHNEIDER M; PHILIP T
      STANDARDS, OPTIONS AND GUIDELINES FOR THE USE OF ANTIEMETICS IN ONCOLOGY

      Bulletin du cancer
    27. WATTEL E; GUERCI A; HECQUET B; ECONOMOPOULOS T; COPPLESTONE A; RESEGOTTI L; VOGLOVA Y; FOUSSARD C; PEGOURIE B; MICHAUX IL; DECONINCK E; STOPPA AM; MUFTI G; OSCIER D; FENAUX P
      A RANDOMIZED TRIAL OF HYDROXYUREA (HY) VERSUS VP16 IN ADVANCED ADULT CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)

      Blood
    28. PLOUVIER B; HOUSSIN R; HECQUET B; COLSON P; HOUSSIER C; WARING MJ; HENICHART JP; BAILLY C
      ANTITUMOR COMBILEXIN - A THIAZOLE-CONTAINING ANALOG OF NETROPSIN LINKED TO AN ACRIDINE CHROMOPHORE

      Bioconjugate chemistry
    29. BONNETERRE J; HECQUET B
      5-HT3 RECEPTOR ANTAGONISTS IN THE PROPHYLAXIS OF ACUTE VOMITING INDUCED BY MODERATELY EMETOGENIC CHEMOTHERAPY - A RANDOMIZED STUDY

      European journal of cancer
    30. DEGARDIN M; BONNETERRE J; HECQUET B; PION JM; ADENIS A; HORNER D; DEMAILLE A
      VINORELBINE (NAVELBINE) AS A SALVAGE TREATMENT FOR ADVANCED BREAST-CANCER

      Annals of oncology
    31. WOLFROM C; RAYNAUD N; MAIGNE J; PAPATHANASSIOU S; CONTI M; KADHOM N; HECQUET B; LEVI F; GAUTIER M; DESCHATRETTE J
      PERIODIC FLUCTUATIONS IN PROLIFERATION OF SV40-TRANSFORMED HUMAN SKINFIBROBLAST LINES WITH PROLONGED LIFE-SPAN

      Cell biology and toxicology
    32. FOURNIER C; HAMON M; HAMON M; WANNEBROUCQ J; PETIPREZ S; PRUVO JP; HECQUET B
      PREPARATION AND PRECLINICAL EVALUATION OF BIORESORBABLE HYDROXYETHYLSTARCH MICROSPHERES FOR TRANSIENT ARTERIAL EMBOLIZATION

      International journal of pharmaceutics
    33. MESTDAGH N; POMMERY N; SAUCIER JM; HECQUET B; FOURNIER C; SLOMIANNY C; TEISSIER E; HENICHART JP
      CHEMORESISTANCE TO DOXORUBICIN AND CISPLATIN IN A MURINE CELL-LINE - ANALYSIS OF P-GLYCOPROTEIN, TOPOISOMERASE-II ACTIVITY, GLUTATHIONE ANDRELATED ENZYMES

      Anticancer research
    34. BOUGHATTAS NA; HECQUET B; FOURNIER C; BRUGUEROLLE B; TRABELSI H; BOUZOUITA K; OMRANE B; LEVI F
      COMPARATIVE PHARMACOKINETICS OF OXALIPLATIN (L-OHP) AND CARBOPLATIN (CBDCA) IN MICE WITH REFERENCE TO CIRCADIAN DOSING TIME

      Biopharmaceutics & drug disposition
    35. CHEVALIEREVAIN V; BONNETERRE J; ADENIS A; PION JM; HECQUET B
      LOSS OF EFFICIENCY OF ONDANSETRON-DEXAMETHASONE DURING SUCCESSIVE COURSES IN FEMALE-PATIENTS RECEIVING HIGH-DOSE CISPLATIN

      Bulletin du cancer
    36. HECQUET B
      NEW MOLECULES WITH POTENTIAL ANTITUMORAL EFFECTS

      Bulletin du cancer
    37. WATTEL E; PREUDHOMME C; HECQUET B; VANRUMBEKE M; QUESNEL B; DERVITE I; MOREL P; FENAUX P
      P53 MUTATIONS ARE ASSOCIATED WITH RESISTANCE TO CHEMOTHERAPY AND SHORT SURVIVAL IN HEMATOLOGIC MALIGNANCIES

      Blood
    38. WATTEL E; PREUDHOMME C; HECQUET B; VANRUMBEKE M; QUESNEL B; DERVITE I; MOREL P; FENAUX P
      P53 MUTATIONS ARE ASSOCIATED WITH RESISTANCE TO CHEMOTHERAPY AND SHORT SURVIVAL IN HEMATOLOGIC MALIGNANCIES

      Blood
    39. FENAUX P; WATTEL E; ARCHIMBAUD E; SANZ M; HECQUET B; FEGUEUX N; GUERCI A; LINK H; FEY M; CASTAIGNE S; DEGOS L
      PROLONGED FOLLOW-UP CONFIRMS THAT ALL-TRANS-RETINOIC ACID FOLLOWED BYCHEMOTHERAPY REDUCES THE RISK OF RELAPSE IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA

      Blood
    40. BONNETERRE J; ADENIS A; PION JM; CAMBIER L; KAMUS E; HECQUET B
      AMINOGLUTETHIMIDE (AG) AND HYDROCORTISONE (HC) IN BONE METASTASES - ARETROSPECTIVE STUDY

      Journal of steroid biochemistry and molecular biology
    41. WATTEL E; HECQUET B; GRAHEK D; HEBBAR M; MOREL P; LAI JL; BAUTERS F; FENAUX P
      LONG-TERM SURVIVORS IN MYELODYSPLASTIC SYNDROMES - A REPORT ON 63 CASES AND COMPARISON WITH SHORT AND INTERMEDIATE SURVIVORS

      Leukemia research
    42. MORIERTEISSIER E; BOITTE N; HELBECQUE N; BERNIER JL; POMMERY N; DUVALET JL; FOURNIER C; HECQUET B; CATTEAU JP; HENICHART JP
      SYNTHESIS AND ANTITUMOR PROPERTIES OF AN ANTHRAQUINONE BISUBSTITUTED BY THE COPPER CHELATING PEPTIDE GLY-GLY-L-HIS

      Journal of medicinal chemistry
    43. ADENIS A; PEYRAT JP; HECQUET B; QUANDALLE P; LEBLANC E; VANSEYMORTIER L; BONNETERRE J
      EXPRESSION OF INSULIN-LIKE GROWTH FACTOR-I RECEPTORS (IGF1-R) IN HUMAN COLORECTAL CANCERS AND COLORECTAL PRECANCEROUS CONDITIONS

      Gastroenterology
    44. ADENIS A; PEYRAT JP; QUANDALLE P; HECQUET B; BONNETERRE J
      INSULIN-LIKE GROWTH FACTOR-I RECEPTORS (IGF1-R) IN INFLAMMATORY BOWELDISEASES

      Gastroenterology
    45. ADENIS A; PEYRAT JP; HECQUET B; QUANDALLE P; GIARD S; BONNETERRE J
      INSULIN-LIKE GROWTH FACTOR-I RECEPTORS (IGF1-R) CONCENTRATIONS IN RESECTED HUMAN GASTRIC-CANCER

      Gastroenterology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/08/20 alle ore 00:44:51